A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes

NCT05996380 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

T2DM

Interventions

DRUG: SHR-3167
DRUG: SHR-3167 Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.